Associations of new-onset atrial fibrillation and severe visual impairment in type 2 diabetes: A multicenter nationwide study
Wisit Kaewput, Ram Rangsin, Department of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok 10400, Thailand
Charat Thongprayoon, Wisit Cheungpasitporn, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States
Tarun Bathini, Department of Internal Medicine, University of Arizona, Tucson, AZ 85721, United States
Michael A Mao, Department of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL 32224, United States
Author contributions: Kaewput W, Thongprayoon C and Cheungpasitporn W contributed to conceptualization; Kaewput W contributed to conceptualization data curation; Kaewput W, Thongprayoon C and Cheungpasitporn W contributed to formal analysis; Kaewput W and Thongprayoon C contributed to investigation; Kaewput W, Thongprayoon C and Cheungpasitporn W contributed to methodology; Rangsin R contributed to project administration; Rangsin R, Bathini T, Mao MA and Cheungpasitporn W contributed to supervision; Kaewput W and Thongprayoon C contributed to validation; Kaewput W, Thongprayoon C and Mao MA contributed to writing–original draft; Kaewput W, Thongprayoon C, Rangsin R, Bathini T, Mao MA and Cheungpasitporn W contributed to writing, review and editing.
Institutional review board statement: This study was approved by both the Institutional Review Board of the Royal Thai Army Medical Department and the Ethical Review Committee for Research in Human Subjects, the Ministry of Public Health of Thailand (IRB# S007h/54).
Informed consent statement: All patients were recruited from the outpatient clinic. Written informed consent was obtained from patients before enrolment.
Conflict-of-interest statement: The authors deny any conflict of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wisit Cheungpasitporn, FACP, FASN, FAST, Associate Professor, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. email@example.com
Received: March 31, 2021
Peer-review started: April 1, 2021
First decision: May 11, 2021
Revised: May 20, 2021
Accepted: July 19, 2021
Article in press: July 19, 2021
Published online: August 26, 2021